Literature DB >> 21128202

Antileishmanial Germacranolides from Calea zacatechichi.

Hankui Wu1, Frank R Fronczek, Charles L Burandt, Jordan K Zjawiony.   

Abstract

Phytochemical study of the leaves and stems of Calea zacatechichi Schl. (Asteraceae) led to the isolation of a series of six germacranolides (1-6) with significant antileishmanial activity. The structure of a new compound named by us as calealactone D (1) was determined by NMR and MS, and its absolute configuration by X-ray crystallography. In addition, calealactone E (5) was discovered as a new naturally occurring compound, and the absolute configuration of calealactone C (2) was also determined by X-ray crystallography. All compounds were biologically evaluated in antimicrobial and antiprotozoal assays. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128202     DOI: 10.1055/s-0030-1250584

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

Review 1.  Mexican Plants and Derivates Compounds as Alternative for Inflammatory and Neuropathic Pain Treatment-A Review.

Authors:  Geovanna N Quiñonez-Bastidas; Andrés Navarrete
Journal:  Plants (Basel)       Date:  2021-04-25

2.  Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome.

Authors:  M Sałaga; A Kowalczuk; M Zielinska; A Błażewicz; J Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-12       Impact factor: 3.000

3.  Evaluation of "Dream Herb," Calea zacatechichi, for Nephrotoxicity Using Human Kidney Proximal Tubule Cells.

Authors:  Miriam E Mossoba; Thomas J Flynn; Sanah Vohra; Paddy Wiesenfeld; Robert L Sprando
Journal:  J Toxicol       Date:  2016-09-15

Review 4.  Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.

Authors:  Chonny Herrera Acevedo; Luciana Scotti; Mateus Feitosa Alves; Margareth De Fátima Formiga Melo Diniz; Marcus Tullius Scotti
Journal:  Molecules       Date:  2017-01-03       Impact factor: 4.411

5.  Anti-Hyperglycemic Activity of Major Compounds from Calea ternifolia.

Authors:  Sonia Escandón-Rivera; Araceli Pérez-Vásquez; Andrés Navarrete; Mariana Hernández; Edelmira Linares; Robert Bye; Rachel Mata
Journal:  Molecules       Date:  2017-02-14       Impact factor: 4.411

6.  Systemic Administration of Calea pinnatifida Inhibits Inflammation Induced by Carrageenan in a Murine Model of Pulmonary Neutrophilia.

Authors:  Bruno Matheus de Campos Facchin; Julia Salvan da Rosa; Ana Beatriz Gobbo Luz; Yeo Jim Kinoshita Moon; Tamires Cardoso de Lima; Rosana Casoti; Maique Weber Biavatti; Eduardo Monguilhott Dalmarco; Tânia Silvia Fröde
Journal:  Mediators Inflamm       Date:  2020-01-25       Impact factor: 4.711

Review 7.  The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade.

Authors:  Patrick O Sakyi; Richard K Amewu; Robert N O A Devine; Emahi Ismaila; Whelton A Miller; Samuel K Kwofie
Journal:  Nat Prod Bioprospect       Date:  2021-07-14

8.  Neuropharmacological characterization of the oneirogenic Mexican plant Calea zacatechichi aqueous extract in mice.

Authors:  Maciej Sałaga; Jakub Fichna; Katarzyna Socała; Dorota Nieoczym; Mateusz Pieróg; Marta Zielińska; Anna Kowalczuk; Piotr Wlaź
Journal:  Metab Brain Dis       Date:  2016-01-28       Impact factor: 3.584

9.  The anticancer activity of dichloromethane crude extract obtained from Calea pinnatifida.

Authors:  Gabriela M Marchetti; Karina A Silva; Arianny N Santos; Ilza Mo Sousa; Sirlene V Tinti; Glyn M Figueira; Mary A Foglio; João E Carvalho
Journal:  J Exp Pharmacol       Date:  2012-11-17

10.  Safety of Aqueous Extract of Calea ternifolia Used in Mexican Traditional Medicine.

Authors:  Ma G E González-Yáñez; Catalina Rivas-Morales; María A Oranday-Cárdenas; María J Verde-Star; María A Núñez-González; Eduardo Sanchez; Catalina Leos-Rivas
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-26       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.